Ignite Creation Date:
2025-12-24 @ 12:09 PM
Ignite Modification Date:
2026-01-01 @ 10:34 PM
Study NCT ID:
NCT01156961
Status:
WITHDRAWN
Last Update Posted:
2016-11-02
First Post:
2010-07-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of The Safety Profile of First-line Avastin (Bevacizumab) in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Her2-negative Breast Cancer (AVATAX)
Sponsor:
Hoffmann-La Roche
Organization: